Physician
Internal Medicine
Dr. Katayoun Rezvani, MD
|
|
Give Review
Katayoun Rezvani is an expert in the field of Internal Medicine. Katayoun Rezvani is a published doctor and has 50 publications published. The lastest was: 'Utility of the ELISPOT interferon- release assay to predict the risk of CMV infection in hematopoietic cell transplant recipients.' She accepts Medicare payments and is registered with Medicare.gov.
Publications
- Utility of the ELISPOT interferon-γ release assay to predict the risk of CMV infection in hematopoietic cell transplant recipients.
- Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation.
- Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation.
- General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation.
- Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells. P...
- Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells.
- Concise Review: Umbilical Cord Blood Transplantation: Past, Present, and Future.
- Clinical and biological predictors of outcome following relapse of CML post-allo-SCT.
- Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.
- Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen-Matched Unre...
- Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells.
- Lenalidomide-Induced Graft-Vs.-Leukemia Effect in a Patient With Chronic Lymphocytic Leukemia Who Relapsed After Allogeneic Stem Cell Transplant.
- Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease.
- FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells.
- Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment.
- Cancer vaccines and T cell therapy.
- Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients.
- Improved outcome following allogeneic stem cell transplantation in chronic myeloid Leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1...
- Role of allo-SCT for CML in 2010.
- Management of relapse after allo-SCT for AML and the role of second transplantation.
- Immunotherapy: Can we include vaccines with stem-cell transplantation?
- A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-present...
- The role of the immune system in myelodysplasia: implications for therapy.
- Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.
- Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplan...
- Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid Leukemias but not with acu...
- Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for Acute lymphoblastic leukemia.
- Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with Acute graft-versus-host disease.
- Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic Anemia.
- High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid Leukemia is associated with improved outcome following allogeneic stem cell transplantatio...
- Translational mini-review series on vaccines: Peptide vaccines for myeloid leukaemias.
- Transfer of PR1-specific T-cell clones from donor to recipient by stem cell transplantation and association with GvL activity.
- T-cell depleted Peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome.
- Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after ...
- High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.
- Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous Leukemia.
- Neutrophil granule proteins as targets of Leukemia-specific immune responses.
- T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with Leukemia and healthy donors: identificat...
- The antiLeukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous Leukemia involves NKG2D-target-cell interactions.
- Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib.
- In vitro induction of myeloid Leukemia-specific CD4 and CD8 T cells by CD40 ligand-activated B cells gene modified to express primary granule proteins.
- G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
- Identification and in vitro expansion of CD4+ and CD8+ T cells specific for human neutrophil elastase.
- Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell maligna...
- New developments in allotransplant immunology.
- Clonal dominance of chronic myelogenous Leukemia is associated with diminished sensitivity to the antiproliferative effects of neutrophil elastase.
- Functional Leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous Leukemia before and after ste...
- Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies.
- Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cells.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Lymphoma
- Macroglobulinemia (incl. Waldenstrom's )
- View All
Doctors Specialties
- Hematology
- Internal Medicine
Accepted Insurances
Drug Facts
| NPI NUMBER | 1760749204 | |
| NPPES Provider LastName | REZVANI | |
| NPPES Provider FirstName | KATAYOUN | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 120.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 9.17 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760749204 |
| Last Name Of The Provider | REZVANI |
| First Name Of The Provider | KATAYOUN |
| View All |
Similar Doctors
|
|
Dr. Chinelo I. Azih, MD |
|
Dr. Bhakti Khatri, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Farhan F. Lalani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Salvador R. Garcia, MD |
|
|
Dr. Robert A. Wolff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelina Cairo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle M. Hebert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jianjun Zhang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark A. Lewis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miguel A. Escobar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dongxin Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brittany K. Ragon, MD |
|
|
Dr. Ravin Ratan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Laura L. Whiteley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessie Y. Feng, MD
This Doctor is OpenDoctor Recommended.
|